Dalrada Health

“Illuminate the Cause” to End Cervical Cancer

By the year 2050, a world without cervical cancer is possible. Today, however, is a much different story. Cervical cancer currently has the fourth-highest mortality rate among women. The cause is HPV (human papillomavirus), a preventable and treatable disease. HPV does not discriminate by age or gender and, if left undetected, causes cancers in both women and men.

Let’s support putting an end to Cervical cancer.

On November 17th, join Dalrada Health and the world as we raise awareness about early prevention and Cervical cancer screening detection – both are vital resources for supporting the world’s Cervical Cancer Elimination Initiative.


Illuminate the Cause!

Nominate a local monument to be lit in the color teal.

WORLD CERVICAL CANCER ELIMINATION INITIATIVE 1st ANNIVERSARY

November 17, 2021


Screening is the cornerstone of reducing the burden of Cervical cancer.

Used worldwide for years, Cervical cancer screening with visual inspection with acetic acid (VIA) is a versatile methodology that is recommended by the World Health Organization’s World Cervical Cancer Elimination Initiative.

Especially for resource-limited countries, Dalrada Health’s cerVIA™ screening kits affordably streamline procedural efficiencies in clinical settings. The results provide precious time in the early detection of cervical cancer – for patients and practitioners alike.

Dalrada Health cares about improving the quality of life for current and future generations that may be affected by Cervical cancer. According to Chief Medical Officer, Payal Keswarpu, “Dalrada Health is committed to the Cervical Cancer Elimination Initiative and has directly contributed to two independent studies in India for Cervical cancer screening. Currently, Dalrada Health is in discussion with several government agencies to be part of the overall elimination strategy.”

A brief timeline of Dalrada Health/cerVIA efforts:
  • December 2019: first cerVIA™ study approved by Clinical Trials Registry – India.
  • February 2020: filed a patent for Dalrada Health’s cerVIA™ Visual Inspection with Acetic Acid.
  • October 2020: cerVIA™ Test Kit clinical trial results featured in The Gynecologist international peer-reviewed open access scholarly journal article Cervical Cancer Screening with Pap Smear and VIA Using a Novel VIA Kit in a Tertiary Care Hospital in South India.
  • November 2020: supports the Cervical Cancer Elimination Initiative with VIA awareness and world education on cervical cancer prevention.
  • March 2021: secondcerVIA™ study approved by Clinical Trials Registry – India.
  • July 2021: Chief Medical Officer, Dr. Payal Keswarpu, shares clinical study results at the 17th World Congress for Cervical Pathology and Colposcopy.
Join Dalrada Health as we support the Cervical Cancer Elimination Initiative with cerVIA™ Test Kits and continue to inform the world about this faster, more efficient way to detect Cervical cancer. Every life is precious. Every minute counts.
cerVIA Test Kit
divider

DALRADA
LATEST NEWS

“Illuminate the Cause” to End Cervical Cancer

By the year 2050, a world without cervical cancer is possible. Today, however, is a much different story. Cervical cancer currently has the fourth-highest mortality rate among women. The cause is HPV (human papillomavirus), a preventable and treatable disease. HPV does not discriminate by age or gender and, if left undetected, causes cancers in both women and men.

Let’s support putting an end to Cervical cancer.

On November 17th, join Dalrada Health and the world as we raise awareness about early prevention and Cervical cancer screening detection – both are vital resources for supporting the world’s Cervical Cancer Elimination Initiative.


Illuminate the Cause!

Nominate a local monument to be lit in the color teal.

WORLD CERVICAL CANCER ELIMINATION INITIATIVE 1st ANNIVERSARY

November 17, 2021


Screening is the cornerstone of reducing the burden of Cervical cancer.

Used worldwide for years, Cervical cancer screening with visual inspection with acetic acid (VIA) is a versatile methodology that is recommended by the World Health Organization’s World Cervical Cancer Elimination Initiative.

Especially for resource-limited countries, Dalrada Health’s cerVIA™ screening kits affordably streamline procedural efficiencies in clinical settings. The results provide precious time in the early detection of cervical cancer – for patients and practitioners alike.

Dalrada Health cares about improving the quality of life for current and future generations that may be affected by Cervical cancer. According to Chief Medical Officer, Payal Keswarpu, “Dalrada Health is committed to the Cervical Cancer Elimination Initiative and has directly contributed to two independent studies in India for Cervical cancer screening. Currently, Dalrada Health is in discussion with several government agencies to be part of the overall elimination strategy.”

A brief timeline of Dalrada Health/cerVIA efforts:
  • December 2019: first cerVIA™ study approved by Clinical Trials Registry – India.
  • February 2020: filed a patent for Dalrada Health’s cerVIA™ Visual Inspection with Acetic Acid.
  • October 2020: cerVIA™ Test Kit clinical trial results featured in The Gynecologist international peer-reviewed open access scholarly journal article Cervical Cancer Screening with Pap Smear and VIA Using a Novel VIA Kit in a Tertiary Care Hospital in South India.
  • November 2020: supports the Cervical Cancer Elimination Initiative with VIA awareness and world education on cervical cancer prevention.
  • March 2021: secondcerVIA™ study approved by Clinical Trials Registry – India.
  • July 2021: Chief Medical Officer, Dr. Payal Keswarpu, shares clinical study results at the 17th World Congress for Cervical Pathology and Colposcopy.
Join Dalrada Health as we support the Cervical Cancer Elimination Initiative with cerVIA™ Test Kits and continue to inform the world about this faster, more efficient way to detect Cervical cancer. Every life is precious. Every minute counts.
cerVIA Test Kit
divider

DALRADA
LATEST NEWS

Skip to content